General Information of Drug (ID: DMWY0TN)

Drug Name
LICOAGROCHACONE A Drug Info
Synonyms
licochalcone a; 58749-22-7; Licochalcone-A; UNII-JTV5467968; 3-Dimethylallyl-4,4'-dihydroxy-6-methoxychalcone; CHEMBL139702; C21H22O4; JTV5467968; (E)-3-[5-(1,1-Dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hydroxyphenyl)-2-propen-1-one; Licochalcone-A, Synthetic; Q-100677; (E)-3-[5-(1,1-dimethylallyl)-4-hydroxy-2-methoxy-phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; 2-Propen-1-one, 3-(5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)-, (E)-
Cross-matching ID
PubChem CID
5318998
ChEBI ID
CHEMBL139702
CAS Number
CAS 58749-22-7
TTD Drug ID
D08GEN

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Oxidative phosphorylation 2.37 0.00e+0 93/133 (69.92%) ATP6V1C1;NDUFB5;ATP6V1D;...
Ribosome 2.17 0.00e+0 113/158 (71.52%) MRPS16;RPS4Y1;RPL13;...
Mineral absorption 2.07 0.00e+0 48/60 (80%) HMOX1;STEAP1;ATP2B1;...
Epithelial cell signaling in Helicobacter pylori infect... 1.97 2.45e-3 62/70 (88.57%) CXCL8;ATP6V1C1;MAPK13;...
Nitrogen metabolism 1.96 1.96e-3 16/17 (94.12%) CA2;GLUL;CA4;...
Folate biosynthesis 1.96 1.63e-3 23/26 (88.46%) AKR1C3;AKR1B10;GCH1;...
Collecting duct acid secretion 1.96 1.40e-3 22/27 (81.48%) CA2;ATP6V1C1;ATP6V1D;...
Thiamine metabolism 1.85 6.12e-3 12/15 (80%) AK4;TPK1;AK5;...
Citrate cycle (TCA cycle) 1.85 5.44e-3 30/30 (100%) DLD;ACLY;PCK1;...
Mismatch repair 1.83 6.86e-3 22/23 (95.65%) PCNA;RPA3;RPA2;...
IL-17 signaling pathway 1.81 1.07e-2 84/94 (89.36%) CXCL8;CXCL5;S100A7;...
SNARE interactions in vesicular transport 1.77 1.47e-2 19/33 (57.58%) BET1;STX3;SNAP29;...
Amyotrophic lateral sclerosis 1.72 3.09e-2 267/364 (73.35%) GRIA2;MAPK13;DAXX;...
Proximal tubule bicarbonate reclamation 1.71 3.22e-2 21/23 (91.3%) CA2;SLC4A4;PCK1;...
DNA replication 1.67 3.92e-2 34/36 (94.44%) PCNA;RPA3;MCM6;...
Parkinson disease 1.66 3.92e-2 176/249 (70.68%) PPIF;CALML4;DAXX;...
Non-alcoholic fatty liver disease 1.66 3.74e-2 126/155 (81.29%) CXCL8;MAPK13;CASP7;...
Rheumatoid arthritis 1.66 3.54e-2 78/93 (83.87%) CXCL8;CXCL5;ATP6V1C1;...
TNF signaling pathway 1.66 3.71e-2 103/112 (91.96%) CXCL5;MAPK13;CASP7;...
Diabetic cardiomyopathy 1.65 3.87e-2 162/203 (79.8%) GAPDH;PPIF;CYBA;...
Thermogenesis 1.64 4.06e-2 173/232 (74.57%) KDM3A;MAPK13;CPT1A;...
Legionellosis 1.64 3.96e-2 51/57 (89.47%) CXCL8;EEF1A2;CASP7;...
Phosphonate and phosphinate metabolism 1.63 4.43e-2 5/6 (83.33%) CHPT1;CEPT1
Primary immunodeficiency -2.09 0.00e+0 33/38 (86.84%) CD19;CD3E;AICDA;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.01uM - 10uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 3H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.04uM - 10uM 24H
Fibroblast
Nasopharyngeal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
FIBRNPC CVCL_UK07 Homo sapiens 10uM 6H, 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.01uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 24H